G2 Investment Partners Management LLC Miromatrix Medical Inc. Transaction History

G2 Investment Partners Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.19 - $1.94 $14,371 - $23,429	-12,077 Reduced 6.68%	168,723 $221,000
Q2 2023 Aug 14, 2023	SELL	$0.92 - $2.03 $53,440 - $117,918	-58,088 Reduced 24.32%	180,800 $316,000
Q1 2023 May 15, 2023	SELL	$1.45 - $3.49 $272,417 - $655,680	-187,874 Reduced 44.02%	238,888 $401,000
Q4 2022 Feb 14, 2023	SELL	$2.5 - $4.44 $146,095 - $259,464	-58,438 Reduced 12.04%	426,762 $1.28 Million
Q3 2022 Nov 14, 2022	SELL	$2.27 - $4.86 $123,285 - $263,951	-54,311 Reduced 10.07%	485,200 $2.13 Million

Q2 2022 Aug 15, 2022	SELL	$3.36 - $4.32 $180,744 - $232,385	-53,793 Reduced 9.07%	539,511 $2.15 Million
Q1 2022 May 16, 2022	SELL	$2.03 - $4.73 $186,098 - $433,618	-91,674 Reduced 13.38%	593,304 $2.35 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $9.4 $22,285 - $47,075	5,008 Added 0.74%	684,978 $3.21 Million
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.75 $467,610 - $903,337	70,850 Added 11.63%	679,970 $4.73 Million
Q2 2021 Aug 16, 2021	BUY	$11.65 - $15.24 $7.1 Million - $9.28 Million	609,120 New	609,120 $7.1 Million

Ticker MIRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,899,200
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...

Get notified when there are updates to the investment portfolio of G2 Investment Partners Management LLC, based on Form 13F filings with the SEC.

Stay updated on G2 Investment Partners Management LLC with notifications on news.